Ceftazidime-avibactam resistance and restoration of carbapenem susceptibility in KPC-producing Klebsiella pneumoniae infections: A case series

Suzanne Van Asten(Leiden University Medical Center), A.T. Bernards(Leiden University Medical Center), Marco Iannaccone(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Matteo Boattini(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Gabriele Bianco(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Margriet E. M. Kraakman(Leiden University Medical Center), Cristina Costa(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Rossana Cavallo(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)
Journal of Infection and Chemotherapy
February 6, 2021
10.1016/j.jiac.2021.01.014
Cited by 21

Related Papers

IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes‐related foot infections (IWGDF/IDSA 2023)
|Diabetes/Metabolism Research and Reviews|2023|283
In vitro activity of cefiderocol against ceftazidime-avibactam susceptible and resistant KPC-producing Enterobacterales: cross-resistance and synergistic effects
|European Journal of Clinical Microbiology & Infectious Diseases|2021|51
RESIST-5 O.O.K.N.V. and NG-Test Carba 5 assays for the rapid detection of carbapenemase-producing Enterobacterales from positive blood cultures: a comparative study
|Journal of Hospital Infection|2020|46
Carbapenemase detection testing in the era of ceftazidime/avibactam-resistant KPC-producing Enterobacterales: A 2-year experience
|Journal of Global Antimicrobial Resistance|2021|46
Increased <i>bla</i> <sub>KPC</sub> Copy Number and OmpK35 and OmpK36 Porins Disruption Mediated Resistance to Imipenem/Relebactam and Meropenem/Vaborbactam in a KPC-Producing Klebsiella pneumoniae Clinical Isolate
|Antimicrobial Agents and Chemotherapy|2022|44